2010
DOI: 10.2353/ajpath.2010.100107
|View full text |Cite
|
Sign up to set email alerts
|

Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
23
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 25 publications
2
23
1
Order By: Relevance
“…The latter model is supported by our recent observation that hepatocytes appear within the rodent pancreas after a relatively short period of elevated glucocorticoid treatment . Furthermore, in a transgenic mouse model of sustained elevated circulating glucocorticoid levels, the exocrine pancreas transdifferentiates into hepatocyte-like tissue and mice begin to malabsorb and lose weight, an effect reversed by feeding mice with pancreatic porcine enzymes (Wallace et al, 2010). Thus, hepatocytes appear in the pancreas not only after extensive damage (Rao et al, 1988;Yeldandi et al, 1990;Krakowski et al, 1999;Yamaoka et al, 2002) or following overexpression of certain growth factors (Krakowski et al, 1999;Yamaoka et al, 2002), but also in response to elevated glucocorticoid levels.…”
Section: Discussionmentioning
confidence: 99%
“…The latter model is supported by our recent observation that hepatocytes appear within the rodent pancreas after a relatively short period of elevated glucocorticoid treatment . Furthermore, in a transgenic mouse model of sustained elevated circulating glucocorticoid levels, the exocrine pancreas transdifferentiates into hepatocyte-like tissue and mice begin to malabsorb and lose weight, an effect reversed by feeding mice with pancreatic porcine enzymes (Wallace et al, 2010). Thus, hepatocytes appear in the pancreas not only after extensive damage (Rao et al, 1988;Yeldandi et al, 1990;Krakowski et al, 1999;Yamaoka et al, 2002) or following overexpression of certain growth factors (Krakowski et al, 1999;Yamaoka et al, 2002), but also in response to elevated glucocorticoid levels.…”
Section: Discussionmentioning
confidence: 99%
“…2A. In the Tg(Crh) mouse model of Cushing's disease, which results in widespread expression of hepatocyte-specific gene expression in the acinar pancreas by 21 weeks of age (Wallace et al, 2010b), Sgk1c was also induced from undetectable levels in the pancreas (Fig. 2B).…”
Section: Sgk1 Is Induced By Dex Treatment In B-13 Cellsmentioning
confidence: 93%
“…Tg(Crh) transgenic mice overexpressing a rat corticotrophin releasing factor transgene that results in chronic elevated circulating glucocorticoid and Cushing's disease (Stenzel-Poore et al, 1992;Wallace et al, 2010b) were obtained from the Jackson 411 Role for SGK1 in transdifferentiation hSGK1A KD mutant pFLAG-CMV2 SGK1A-K127M. SGK1A sequence mutated at residue 127.…”
Section: Animalsmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, CRH-Tg mice have large increases in adipose triglyceride futile cycling with increased rate of both lipolysis and reesterifi cation [ 82 ]. CRH-Tg mice display age-dependent malabsorption that is due to a "transdifferentiation" of exocrine pancreas to express hepatocyte markers [ 83 ].…”
Section: Non-gr Mutants Relevant To Glucocorticoid Signalingmentioning
confidence: 99%